Propanc Biopharma, Inc. (PPCB) › Total AssetsPropanc Biopharma, Inc. (PPCB) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $10.81M2012: $46.3K2013: $1.7K2014: $113.7K2015: $627.1K2016: $379.1K2017: $95.1K2018: $71.4K2019: $101.7K2020: $98.5K2021: $13.1K2022: $81.7K2023: $60.3K2024: $72.4K2025: $19.63M$19.63M2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$19.63M+27028.9%2024$72.4K+20.0%2023$60.3K-26.1%2022$81.7K+523.2%2021$13.1K-86.7%2020$98.5K-3.1%2019$101.7K+42.4%2018$71.4K-24.9%2017$95.1K-74.9%2016$379.1K-39.5%2015$627.1K+451.3%2014$113.7K+6410.9%2013$1.7K-96.2%2012$46.3K-99.6%2011$10.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share